한국어
English
日本語
中文(简体)COVAXFLU (Influenza Split Vaccine)
15μg
Prescription medication · Combination
Korea Vaccine Co., Ltd.
Inactivated Influenza Virus Antigen Type A is a vaccine component for the prevention of Influenza A virus infection.
MFDS ingredient code M267777
This component is an antigen that has been inactivated and purified from the Influenza A virus. It is included in the vaccine to help the body develop immunity to the virus. It is primarily used for the prevention of influenza infection.
When injected into the body, this antigen allows the immune system to recognize the Influenza A virus. This leads to the production of antibodies and creates immunological memory to respond quickly in the event of a real viral infection.
Approved uses differ by product. Check each product's information for its actual use.
This antigen is in a safe, inactivated form rather than a live virus. It is characterized by being a split vaccine that includes only parts of the virus, thereby reducing the risk of side effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.